Name | Cyclocytidine hydrochloride |
Synonyms | Cyclocytidine hydrochloride 2,2'-O-Cyclocytidine Hydrochloride 2,2'-dihydro-1-beta-D-arabinofuranosylcytosine hydrochloride 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride |
CAS | 10212-25-6 |
EINECS | 233-515-6 |
InChI | InChI=1/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1 |
InChIKey | KZOWNALBTMILAP-JBMRGDGGSA-N |
Molecular Formula | C9H11N3O4· HCl |
Molar Mass | 261.66 |
Melting Point | 269-270℃ |
Boling Point | 442℃ at 760 mmHg |
Specific Rotation(α) | -21 ° (C=2, H2O) |
Appearance | Morphology Powder |
Color | White |
Merck | 14,629 |
Storage Condition | Inert atmosphere,2-8°C |
Sensitive | Easily absorbing moisture |
MDL | MFCD00012636 |
Physical and Chemical Properties | Chemical quality This product is white needle-like crystal or crystalline powder; odorless; soluble in water, slightly soluble in methanol and ethanol, almost insoluble in ether, benzene and chloroform; mp256-262 ℃ (decomposition). specific rotation -20 ° -23 °(c = 2 g/ml,H2O). |
Use | Effective for all types of acute leukemia and meningeal leukemia |
Safety Description | S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 2 |
RTECS | LV2615000 |
HS Code | 29213000 |
antineoplastic agents.